Update of newborn screening and therapy for congenital hypothyroidism

Pediatrics

Volumn 117, Issue 6, 2006, Pages 2290-2303

  Rose, Susan R ^g   Brown, Rosalind S ^g   Foley, Thomas ^g   Kaplowitz, Paul B ^g   Kaye, Celia I ^g   Sundararajan, Sumana ^g   Varma, Surendra K ^g   Brink, Stuart J ^g   Clarke, William L ^g   Silverstein, Janet ^g   Scales, Rosemary ^a   Laskosz, Laura ^g   Schaefer, G Bradley ^g   Bull, Marilyn J ^g   Enns, Gregory M ^g   Gruen, Jeffrey R ^g   Hersh, Joseph H ^g   Mendelsohn, Nancy J ^g   Saal, Howard M ^g   Goldberg, James D ^b   Hanson, James W ^c   Lloyd Puryear, Michele A ^d   Rasmussen, Sonja A ^e   Spire, Paul ^g   Hollowell Jr , Joseph G ^g   Bernet, Victor J ^g   Belin, Ruth M ^g   Burman, Kenneth D ^g   Fein, Henry G ^g   Hennessey, James V ^g   Lamm, Steven H ^g   Mitchell, Marvin L ^g   Park, Hee Myung ^g   Robbins, Richard J ^g   Bahn, Rebecca S ^g   Becker, David V ^g   Franklyn, Jayne A ^g   Robbins, Jacob ^g   Van Middlesworth, Lester ^g   Levitsky, Lynne L ^g   Rogol, Alan D ^g   Radovich, Sally ^f   more..

^a Pediatric Endocrinology Nursing Society   (United States)

^b AMERICAN COLLEGE OF OBSTETRICIANS AND GYNECOLOGISTS   (United States)

^c American College of Medical Genetics   (United States)

^d HEALTH RESOURCES AND SERVICES ADMINISTRATION   (United States)

^e CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^f Drug and Therapeutics Drug Committee

^g NONE

Author keywords

Congenital hypothyroidism; Newborn screening; Thyroid hormone; Thyroid stimulating hormone

Indexed keywords

DOPAMINE; GLUCOCORTICOID; LEVOTHYROXINE; THYROTROPIN; THYROXINE;

ARTICLE; BODY HEIGHT; CLINICAL EXAMINATION; CLINICAL FEATURE; CONGENITAL HYPOTHYROIDISM; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUOROIMMUNOASSAY; FOLLOW UP; GROWTH RATE; HORMONAL THERAPY; HUMAN; LABORATORY TEST; MENTAL DEFICIENCY; NEWBORN SCREENING; PHYSICIAN; PREMATURITY; PRIORITY JOURNAL; PROGNOSIS; VERY LOW BIRTH WEIGHT; BLOOD; DECISION TREE; NEWBORN; REVIEW;

CONGENITAL HYPOTHYROIDISM; DECISION TREES; FOLLOW-UP STUDIES; HUMANS; INFANT, NEWBORN; NEONATAL SCREENING; THYROTROPIN; THYROXINE;

EID: 33745318070     PISSN: 00314005     EISSN: 02105721     Source Type: Journal    
DOI: 10.1542/peds.2006-0915     Document Type: Article

References (87)

1. Gruters A, Biebermann H, Krude H. Neonatal thyroid disorders. Horm Res. 2003;59(suppl 1):24-29
2. Zoeller RT. Editorial: local control of the timing of thyroid hormone action in the developing human brain. J Clin Endocrinol Metab. 2004;89:3114-3116
3. Heindel JJ, Zoeller RT. Thyroid hormone and brain development: translating molecular mechanisms to population risk. Thyroid. 2003;13:1001-1004
4. Knobel M, Medeiros-Neto G. An outline of inherited disorders of the thyroid hormone generating system. Thyroid. 2003;13:771-801
5. Kopp P. Perspective: genetic defects in the etiology of congenital hypothyroidism. Endocrinology. 2002;143:2019-2024
6. Radetti G, Zavallone A, Gentili L, Beck-Peccoz P, Bona G. Foetal and neonatal thyroid disorders. Minerva Pediatr. 2002;54:383-400
7. Anderson GW, Schoonover CM, Jones SA. Control of thyroid hormone action in the developing rat brain. Thyroid. 2003;13:1039-1056
8. Bernal J, Guadano-Ferraz A, Morte B. Perspectives in the study of thyroid hormone action on brain development and function. Thyroid. 2003;13:1005-1012
9. American Academy of Pediatrics, Section on Endocrinology and Committee on Genetics; American Thyroid Association, Committee on Public Health. Newborn screening for congenital hypothyroidism: recommended guidelines. Pediatrics. 1993;91:1203-1209
10. Vulsma T, Gons MH, de Vijlder JJ. Maternal-fetal transfer of thyroxine in congenital hypothyroidism due to a total organification defect or thyroid agenesis. N Engl J Med. 1989;321:13-16
11. Rose SR. Disorders of thyrotropin synthesis, secretion, and function. Curr Opin Pediatr. 2000;12:375-381
12. Ruiz de Ona C, Obregon MJ, Escobar de1 Rey F, Morreale de Escobar G. Developmental changes in rat brain 5′-deiodinase and thyroid hormones during the fetal period: the effects of fetal hypothyroidism and maternal thyroid hormones. Pediatr Res. 1988;24:588-594
13. Kester MH, Martinez de Mena R, Obregon MJ, et al. Iodothyronine levels in the human developing brain: major regulatory roles of iodothyronine deiodinases in different areas. J Clin Endocrinol Metab. 2004;89:3117-3128
14. Glinoer D. Potential consequences of maternal hypothyroidism on the offspring: evidence and implications. Horm Res. 2001;55:109-114
15. Haddow JE, Palomaki GE, Allan WC, et al. Maternal thyroid during pregnancy and subsequent neuropsychological development of the child. N Engl J Med. 1999;341:549-555
16. Lavado-Autric R, Auso E, Garcia-Velasco JV, et al. Early maternal hypothyroxinemia alters histogenesis and cerebral cortex cytoarchitecture of the progeny. J Clin Invest. 2003;111:1073-1082
17. Liu J, Erlichman B, Weinstein LS. The stimulatory G protein alpha-subunit Gs alpha is imprinted in human thyroid glands: implications for thyroid function in pseudohypoparathyroidism types 1A and 1B. J Clin Endocrinol Metab. 2003;88:4336-4341
18. Mirabella G, Feig D, Astzalos E, Perlman K, Rovet JF. The effect of abnormal intrauterine thyroid hormone economies on infant cognitive abilities. J Pediatr Endocrinol Metab. 2000;13:191-194
19. Morreale de Escobar G, Obregon MJ, Escobar del Rey F. Is neuropsychological development related to maternal hypothyroidism or to maternal hypothyroxinemia? J Clin Endocrinol Metab. 2000;85:3975-3987
20. Alexander EK, Marqusee E, Lawrence J, Jarolim P, Fischer GA, Larsen PR. Timing and magnitude of increases in levothyroxine requirements during pregnancy in women with hypothyroidism. N Engl J Med. 2004;351:241-249
21. de Escobar GM, Obregon MJ, del Rey FE. Maternal thyroid hormones early in pregnancy and fetal brain development. Best Pract Res Clin Endocrinol Metab. 2004;18:225-248
22. Dussault JH, Coulombe P, Laberge C, Letarte J, Guyda H, Khoury K. Preliminary report on a mass screening program for neonatal hypothyroidism. J Pediatr. 1975;86:670-674
23. Working Group on Neonatal Screening of the European Society for Paediatric Endocrinology. Revised guidelines for neonatal screening programmes for primary congenital hypothyroidism. Horm Res. 1999;52:49-52
24. LaFranchi SH, Snyder DB, Sesser DE, et al. Follow-up of newborns with elevated screening T4 concentrations. J Pediatr. 2003;143:296-301
25. Waller DK, Anderson JL, Lorey F, Cunningham GC. Risk factors for congenital hypothyroidism: an investigation of infant's birth weight, ethnicity, and gender in California, 1990-1998. Teratology. 2000;62:36-41
26. DeLange F, Burgi H, Chen ZP, Dunn JT. World status of monitoring iodine deficiency disorders control programs. Thyroid. 2002;12:915-924
27. Zimmermann MB, Zeder C, Chaouki N, Saad A, Torresani T, Hurrell RF. Dual fortification of salt with iodine and microencapsulated iron: a randomized, double-blind, controlled trial in Moroccan schoolchildren. Am J Clin Nutr. 2003;77:425-432
28. Hassanien MH, Hussein LA, Robinson EN, Preston Mercer L. Human iodine requirements determined by the saturation kinetics model. J Nutr Biochem. 2003;14:280-287
29. Hollowell JG, Staehling NW, Hannon WH, et al. Iodine nutrition in the United States: trends and public health implications - iodine excretion data from National Health and Nutrition Examination Surveys I and III (1971-1974 and 1988-1994). J Clin Endocrinol Metab. 1998;83:3401-3408
30. Delange F, de Benoist B, Pretell E, Dunn JT. Iodine deficiency in the world: where do we stand at the turn of the century? Thyroid. 2001;11:437-447
31. Glinoer D. Pregnancy and iodine. Thyroid. 2001;11:471-481
32. Bartalena L, Bogazzi F, Braverman LE, Martino E. Effects of amiodarone administration during pregnancy on neonatal thyroid function and subsequent neurodevelopment. J Endocrinol Invest. 2001;24:116-130
33. Andersen S, Bruun NH, Pedersen KM, Laurberg P. Biologic variation is important for interpretation of thyroid function tests. Thyroid. 2003;13:1069-1078
34. Dussault JH, Morissette J. Higher sensitivity of primary thyrotropin in screening for congenital hypothyroidism: a myth? J Clin Endocrinol Metab. 1983;56:849-852
35. Heyerdahl S, Oerbeck B. Congenital hypothyroidism: developmental outcome in relation to levothyroxine treatment variables. Thyroid. 2003;13:1029-1038
36. Murphy N, Hume R, van Tor H, et al. The hypothalamicpituitary-thyroid axis in preterm infants: changes in the first 24 hours of postnatal life. J Clin Endocrinol Metab. 2004;89:2824-2831
37. Allen D, Sieger JE, Litsheim T, Duck SC. Age-adjusted thyrotropin criteria for neonatal screening for hypothyroidism. J Pediatr. 1990;117:309-312
38. Council of Regional Networks for Genetics Services. Newborn Screening Report for 1990. New York, NY: Council of Regional Networks for Genetic Services; 1992
39. Blood Collection on Filter Paper for Neonatal Screening Programs: Approved Standard. Villanova, PA: National Committee for Clinical Laboratory Standards; 1989. NCCLS publication LAI-A
40. Hunter MK, Mandel SH, Sesser DE, et al. Follow-up of newborns with low thyroxine and nonelevated thyroid-stimulating hormone-screening concentrations: results of the 20-year experience in the Northwest Regional Newborn Screening Program. J Pediatr. 1998;132:70-74
41. LaFranchi SH, Hanna CE, Krainz FL, Skeels MR, Miyahira RS, Sesser DE. Screening for congenital hypothyroidism with specimen collection at two time periods: results of the Northwest Regional Screening Program. Pediatrics. 1985;76:734-740
42. Fisher DA. Disorders of the thyroid in the newborn and infant. In: Sperling MA, ed. Clinical Pediatric and Adolescent Endocrinology. Philadelphia, PA: Saunders; 2002:164
43. Calaciura F, Motto RM, Miscio G, et al. Subclinical hypothyroidism in early childhood: a frequent outcome of transient neonatal hyperthyrotropinemia. J Clin Endocrinol Metab. 2002;87:3209-3214
44. Brown RS, Bellisario RL, Botero D, et al. Incidence of transient congenital hypothyroidism due to maternal thyrotropin receptor-blocking antibodies in over one million babies. J Clin Endocrinol Metab. 1996;81:1147-1151
45. Daliva AL, Linder B, DiMartino-Nardi J, Saenger P. Three-year follow-up of borderline congenital hypothyroidism. J Pediatr. 2000;136:53-56
46. Cody D, Kumar Y, Ng SM, Didi M, Smith C. The differing outcomes of hyperthyrotropinaemia. J Pediatr Endocrinol Metab. 2003;16:375-378
47. Hanna CE, Krainz PL, Skeels MR, Miyahara RS, Sesser DE, LaFranchi SH. Detection of congenital hypopituitary hypothyroidism: ten-year experience in the Northwest Regional Screening Program. J Pediatr. 1986;109:959-964
48. Rapaport R, Rose SR, Freemark M. Hypothyroxinemia in the preterm infant: the benefits and risks of thyroxine treatment. J Pediatr. 2001;139:182-188
49. Carrascosa A, Ruiz-Cuevas P, Potau N, et al. Thyroid function in seventy-five healthy preterm infants thirty to thirty-five weeks of gestational age: a prospective and longitudinal study during the first year of life. Thyroid. 2004;14:435-442
50. Van Wassenaer AG, Kok JH, Briet JM, Pijning AM, de Vijlder JJ. Thyroid function in very preterm newborns: possible implications. Thyroid. 1999;9:85-91
51. Asakura Y, Tachibana K, Adachi M, Suwa S, Yamagami Y. Hypothalamo-pituitary hypothyroidism detected by neonatal screening for congenital hypothyroidism using measurement of thyroid-stimulating hormone and thyroxine. Acta Paediatr. 2002;91:172-177
52. Mehta A, Hindmarsh PC, Stanhope RG, Brain CE, Preece MA, Dattani MT. Is the thyrotropin-releasing hormone test necessary in the diagnosis of central hypothyroidism in children? J Clin Endocrinol Metab. 2003;88:5696-5703
53. Netchine I, Sobrier ML, Krude H, et al. Mutations in LHX3 result in a new syndrome revealed by combined pituitary hormone deficiency. Nat Genet. 2000;25:182-186
54. Bonomi M, Proverbio MC, Weber G, Chiumello G, Beck-Peccoz P, Persani L. Hyperplastic pituitary gland, high serum glycoprotein hormone alpha-subunit, and variable circulating thyrotropin (TSH) levels as hallmark of central hypothyroidism due to mutations of the TSH beta gene. J Clin Endocrinol Metab. 2001;86:1600-1604
55. Pohlenz J, Dumitrescu A, Aumann U, et al. Congenital secondary hypothyroidism caused by exon skipping due to a homozygous donor splice site mutation in the TSH beta-subunit gene. J Clin Endocrinol Metab. 2002;87:336-339
56. Pereira DN, Procianoy RS. Effect of perinatal asphyxia on thyroid-stimulating hormone and thyroid hormone levels. Acta Paediatr. 2003;92:339-345
57. Biswas S, Buffery J, Enoch H, Bland M, Markiewicz M, Walters D. Pulmonary effects of triiodothyronine (T3) and hydrocortisone (HC) supplementation in preterm infants less than 30 weeks gestation: results of the THORN trial - thyroid hormone replacement in neonates. Pediatr Res. 2003;53:48-56
58. Kok JH, Briet JM, Van Wassenaer AG. Postnatal thyroid hormone replacement in very preterm infants. Semin Perinatol. 2001;25:417-425
59. Osborn DA. Thyroid hormones for preventing neurodevelopmental impairment in preterm infants. Cochrane Database Syst Rev. 2001;(4):CD001070
60. Perry R, Heinrichs C, Bourdoux P, et al. Discordance of monozygotic twins for thyroid dysgenesis: implications for screening and for molecular pathophysiology. J Clin Endocrinol Metab. 2002;87:4072-4077
61. Larson C, Hermos R, Delaney A, Daley D, Mitchell M. Risk factors associated with delayed thyrotropin elevations in congenital hypothyroidism. J Pediatr. 2003;143:587-591
62. Zoeller TR, Dowling AL, Herzig CT, Iannacone EA, Gauger KJ, Bansal R. Thyroid hormone, brain development, and the environment. Environ Health Perspect. 2002;110(suppl 3):355-361
63. Markou K, Georgopoulos N, Kyriazopoulou V, Vagenakis AG. Iodine-induced hypothyroidism. Thyroid. 2001;11:501-510
64. van Der Zwet WC, Vandenbroucke-Grauls CM, van Elburg RM, Cranendonk A, Zaaijer HL. Neonatal antibody titers against varicella-zoster virus in relation to gestational age, birth weight, and maternal titer. Pediatrics. 2002;109:79-85
65. Muir A, Daneman D, Daneman A, Ehrlich R. Thyroid scanning, ultrasound, and serum thyroglobulin in determining the origin of congenital hypothyroidism. Am J Dis Child. 1988;142:214-216
66. Kreisner E, Camargo-Neto E, Maia CR, Gross JL. Accuracy of ultrasonography to establish the diagnosis and aetiology of permanent primary congenital hypothyroidism. Clin Endocrinol. 2003;59:361-365
67. Bubuteishvili L, Garel C, Czernichow P, Leger J. Thyroid abnormalities by ultrasonography in neonates with congenital hypothyroidism. J Pediatr. 2003;143:759-764
68. Ohnishi H, Inomata H, Watanabe T, et al. Clinical utility of thyroid ultrasonography in the diagnosis of congenital hypothyroidism. Endocr J. 2002;49:293-297
69. Ohnishi H, Sato H, Noda H, Inomata H, Sasaki N. Color Doppler ultrasonography: diagnosis of ectopic thyroid gland in patients with congenital hypothyroidism caused by thyroid dysgenesis. J Clin Endocrinol Metab. 2003;88:5145-5149
70. Cassio A, Cacciari E, Cicognani A, et al. Treatment for congenital hypothyroidism: thyroxine alone or thyroxine plus triiodothyronine? Pediatrics. 2003;111:1055-1060
71. Bongers-Schokking JJ, Koot HM, Wiersma D, Verkerk PH, de Muinck Keizer-Schrama SM. Influence of timing and dose of thyroid hormone replacement on development in infants with congenital hypothyroidism. J Pediatr. 2000;136:292-297
72. Bakker B, Kempers MJ, DeVijlder JJ, et al. Dynamics of the plasma concentrations of TSH, FT4 and T3 following thyroxine supplementation in congenital hypothyroidism. Clin Endocrinol (Oxf). 2002;57:529-537
73. Germak JA, Foley TP Jr. Longitudinal assessment of L-thyroxine therapy for congenital hypothyroidism. J Pediatr. 1990;117:211-219
74. Elmlinger MW, Kuhnel W, Lambrecht HG, et al. Reference intervals from birth to adulthood for serum thyroxine (T4), triiodothyronine (T3), free T3, free T4, thyroxine binding globulin (TBG) and thyrotropin (TSH). Clin Chem Lab Med. 2001;39:973-979
75. Baloch Z, Carayon P, Conte-Devolx B, et al. Laboratory medicine practice guidelines: laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid. 2003;13:3-126
76. Salerno M, Micillo M, Di Maio S, et al. Longitudinal growth, sexual maturation and final height in patients with congenital hypothyroidism detected by neonatal screening. Eur J Endocrinol. 2001;145:377-383
77. Morin A, Guimarey L, Apezteguia M, Ansaldi M, Santucci Z. Linear growth in children with congenital hypothyroidism detected by neonatal screen and treated early: a longitudinal study. J Pediatr Endocrinol Metab. 2002;15:973-977
78. Bongers-Schokking JJ. Pre- and postnatal brain development in neonates with congenital hypothyroidism. J Pediatr Endocrinol Metab. 2001;14(suppl 6):1463-1468
79. Gruters A, Jenner A, Krude H. Long-term consequences of congenital hypothyroidism in the era of screening programmes. Best Pract Res Clin Endocrinol Metab. 2002;16:369-382
80. Oerbeck B, Sundet K, Kase BF, Heyerdahl S. Congenital hypothyroidism: influence of disease severity and L-thyroxine treatment on intellectual, motor, and school-associated outcomes in young adults. Pediatrics. 2003;112:923-930
81. Rovet JF. Congenital hypothyroidism: an analysis of persisting deficits and associated factors. Child Neuropsychol. 2002;8:150-162
82. Rovet J, Daneman D. Congenital hypothyroidism: a review of current diagnostic and treatment practices in relation to neuropsychologic outcome. Paediatr Drugs. 2003;5:141-149
83. Song SI, Daneman D, Rovet J. The influence of etiology and treatment factors in intellectual outcome on congenital hypothyroidism. J Dev Behav Pediatr. 2001;22:376-384
84. Chou YH, Wang PJ. Auditory brainstem evoked potentials in early-treated congenital hypothyroidism. J. Child Neurol. 2002;17:510-514
85. Leneman M, Buchanan L, Rovet J. Where and what visuospatial processing in adolescents with congenital hypothyroidism. J Int Neuropsychol Soc. 2001;7:556-562
86. Eugster EA, LeMay D, Zerin JM, Pescovitz OH. Definitive diagnosis in children with congenital hypothyroidism. J Pediatr. 2004;144:643-647
87. Holtzman C, Slazyk WE, Cordero JF, Hannon WH. Descriptive epidemiology of missed cases of phenylketonuria and congenital hypothyroidism. Pediatrics. 1986;78:553-558